BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30552042)

  • 1. Association of PD-L1 gene rs4143815 C>G polymorphism and human cancer susceptibility: A systematic review and meta-analysis.
    Zou J; Wu D; Li T; Wang X; Liu Y; Tan S
    Pathol Res Pract; 2019 Feb; 215(2):229-234. PubMed ID: 30552042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
    Xie Q; Chen Z; Xia L; Zhao Q; Yu H; Yang Z
    Gene; 2018 Oct; 674():188-194. PubMed ID: 29940275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer.
    Tan D; Sheng L; Yi QH
    Cancer Biomark; 2018 Feb; 21(2):287-297. PubMed ID: 29171986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients.
    Hassan M; Attia MS; Ali-Eldin Z; El Attar G; Elzallat M; Saad HHK; Isaac A
    Tumour Virus Res; 2022 Dec; 14():200249. PubMed ID: 36265835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.
    Yeo MK; Choi SY; Seong IO; Suh KS; Kim JM; Kim KH
    Hum Pathol; 2017 Oct; 68():103-111. PubMed ID: 28851662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Possible Association between PD-1 (Rs11568821, Rs2227981, Rs2227982) and PD-L1 (Rs4143815, Rs2890658) Polymorphisms and Susceptibility to Breast Cancer in a Sample of Southeast Iranian Women.
    Karami S; Sattarifard H; Kiumarsi M; Sarabandi S; Taheri M; Hashemi M; Bahari G; Ghavami S
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):3115-3123. PubMed ID: 33112575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction.
    Shi XL; Mancham S; Hansen BE; de Knegt RJ; de Jonge J; van der Laan LJ; Rivadeneira F; Metselaar HJ; Kwekkeboom J
    J Hepatol; 2016 Jun; 64(6):1274-82. PubMed ID: 26941095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility.
    Qian C; Guo H; Chen X; Shi A; Li S; Wang X; Pan J; Fang C
    J Diabetes Res; 2018; 2018():1614683. PubMed ID: 30534571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients.
    Nomizo T; Ozasa H; Tsuji T; Funazo T; Yasuda Y; Yoshida H; Yagi Y; Sakamori Y; Nagai H; Hirai T; Kim YH
    Sci Rep; 2017 Mar; 7():45124. PubMed ID: 28332580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between
    Hashemi M; Karami S; Sarabandi S; Moazeni-Roodi A; Małecki A; Ghavami S; Wiechec E
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31405171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The blockage signal for PD-L1/CD274 gene variants and their potential impact on lung carcinoma susceptibility.
    Sakran MI; Alalawy AI; Alharbi AA; El-Hefnawy ME; Alzahrani SM; Alfuraydi A; Alzuaibr FM; Zidan NS; Elsaid AM; Toraih EA; Elshazli RM
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111180. PubMed ID: 37939515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of PD-1 and PD-L1 gene polymorphisms with cancer risk: a meta-analysis based on 50 studies.
    Yang M; Liu Y; Zheng S; Geng P; He T; Lu L; Feng Y; Jiang Q
    Aging (Albany NY); 2024 Mar; 16(7):6068-6097. PubMed ID: 38546391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis.
    Yang M; Zou Y; Bai Y; Li M
    J Orthop Sci; 2015 Jan; 20(1):55-63. PubMed ID: 25270018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis.
    Hao X; Xia L; Qu R; Yang X; Jiang M; Zhou B
    Fam Cancer; 2018 Jul; 17(3):459-468. PubMed ID: 29127520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the PD-L1 gene 3'-untranslated region are associated with the expression of PD-L1 in non-small cell lung cancer.
    Ohhara Y; Tomaru U; Kinoshita I; Hatanaka KC; Noguchi T; Hatanaka Y; Amono T; Matsuno Y; Dosaka-Akita H
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23216. PubMed ID: 38169142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
    Li JF; Zheng EQ; Xie M
    Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Polymorphisms with Overall Cancer Susceptibility: An Updated Meta-Analysis of 28 Studies with 60 612 Subjects.
    Zhang W; Song Y; Zhang X
    Med Sci Monit; 2021 May; 27():e932146. PubMed ID: 34024901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of PD-L1 gene polymorphisms and interactions with cooking with solid fuel exposure on tuberculosis.
    Tang K; Wang J; Zhong H; Wang Q; Li Z; Wu C; An R; Lin Y; Tan H; Chen L; Wang M; Chen M
    Public Health Genomics; 2024 May; ():. PubMed ID: 38735285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma.
    Moksud N; Wagner M; Pawełczyk K; Porębska I; Muszczyńska-Bernhard B; Kowal A; Wiśniewski A; Kosacka M; Kończak J; Karpiński P; Frydryk D; Andrzejczak A; Karabon L; Kuśnierczyk P; Jasek M
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6381-6390. PubMed ID: 36759392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
    Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.